Karyopharm reports first quarter 2021 financial results and highlights recent company progress

Newton, mass., may 3, 2021 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq:kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the quarter ended march 31, 2021.

KPTI Ratings Summary

KPTI Quant Ranking